It is possible that the inhibition of neutrophil migration resulting from EZH2 inhibition may have a therapeutic role in diseases associated with excess neutrophilic inflammation, such as adult respiratory distress syndrome. The gene discussed is EZH2; the disease is adult acute respiratory distress syndrome.